A prospective study comparing short versus standard dual antiplatelet therapy in patients with acute myocardial infarction: design and rationale of the TARGET-FIRST trial.

Overview of attention for article published in EuroIntervention, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

news: 3 news outlets
twitter: 38 X users

facebook: 1 Facebook page

Readers on

mendeley: 22 Mendeley

So far, Altmetric has seen 45 X posts from 38 X users, with an upper bound of 174,614 followers.

RT @EuroInterventio: 🆕 Design and rationale of the TARGET-FIRST trial to determine if 1 month of DAPT after STEMI or NSTEMI is safe when us…

RT @EuroInterventio: Design and rationale of the randomised TARGET-FIRST trial on the optimisation of antiplatelet therapy in patients with…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 41 additional X posts.